Davis Polk & Wardwell represented the underwriters in the offering Maravai LifeSciences Holdings, Inc. annunced the $1 billion secondary offering of 20,000,000 shares of Class A common…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
